Shopping Cart 0
Cart Subtotal
USD 0

Worldwide Facial Injectables Market Drivers, Opportunities, Trends, and Forecasts: 2017-2023

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 2500

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 2750

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 3000
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Global Facial Injectables Market-Drivers, Opportunities, Trends, and Forecasts: 2017-2023

Overview: Skin provides a protective barrier to the body by covering all the core structures and is the largest organ in the human body. Skin acts as a mechanical barrier for harmful UV rays and plays a vital role in thermoregulation and water homeostasis. Aging is one of the direct comparisons of the chronological changes in the face, hair, body, and all the visible characteristics that are found comparative. Every individual face ages on its own speed and depends on various environmental factors. However, some basic characteristics are common and natural: loss of a proportion of the skin, glabellar lines, sagging of the eyebrows, sunken eyes, wrinkles, irregular skin surfaces, loss of lip volume, irregular chin contour, and skin discoloration. Apart from aging, the new generation has attracted towards cosmetic industry to look aesthetic and appear more youthful. Most of the advancements made in the dermatology field are to treat various skin diseases and enhance the quality of the skin. The advent of facial injectables has revolutionized the cosmetic industry by providing an individual the most important part of life, which is to look youthful and beautiful.

The factors such as increase in beauty consciousness, growing awareness about facial injections, increasing demand for non-surgical and minimally invasive cosmetic surgeries, and anticipated launch of new products are expected to drive the market growth during the forecast period. The market is witnessing the emerging trends such as increase in demand for combination treatments, rise in medical tourism, and increase in disposable income that will drive the market at a significant pace during the forecast period. The markets in Brazil, India, China, and Russia are expected to grow at a rapid pace during the forecast period as the adoption of cosmetic procedures in these countries is high.

The major products in the market include:

Restylane-Hyaluronic Acid-Based Filler

Juvederm-Hyaluronic Acid-Based Filler

PREVELLE Silk-Hyaluronic Acid-Based Filler

Hydrelle-Hyaluronic Acid-Based Filler

Belotero-Hyaluronic Acid-Based Filler

Cosmoplast-Collagen-Based Fillers

Evolence-Collagen-Based Fillers

Sculptra-Semi-Permanent Fillers

Radiesse-Semi-Permanent Fillers

ArteFill-Permanent Fillers

BOTOX-OnabotulinumtoxinA

Dysport-AbobotulinumtoxinA

Xeomin-IncobotulinumtoxinA

Myobloc-RimabotulinumtoxinB

The market is monopolistic and dominated by Allergan, which has more than 45% market share in the total global facial injectables market. The market is fragmented with the presence of many global and local players. The factors such as increased prevalence of skin related disorders, growing popularity about spas and beauty clinics, focus on improving facial appearances, increasing adoption of non-invasive cosmetic surgeries, and increasing disposable income are driving the market growth.

Market Analysis: The Global Facial Injectables Market is estimated to witness a CAGR of 10.42% during the forecast period 2017-2023. The market is analyzed based on three segments-product type, end-users, and regions.

Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (ROW). The Americas is set to be the leading region for the facial injectables market growth followed by Europe. Asia Pacific and ROW are set to be the emerging regions. Brazil is set to be the most attractive destination, and in Latin America, the popularity and the usage of facial injectables are expected to increase in the coming years.

Product Analysis: Botox and dermal fillers are the most popular treatments among all class of people and have become the most common aesthetic procedures among end-users. Botox dominated the market, while dermal fillers segment is positioned above due to the huge adoption of a wide variety of fillers owing to its growing use in many areas. In 2016, there were about 7.05 million injections of botulinum toxin worldwide. It is because of the shift in cultural thinking, high spending on beauty products, and increased brand popularity. On an average, women have started spending USD 300-USD 500 billion a year on beauty products. Moreover, advances in technologies such as injecting techniques and molecular changes adopted in filler materials have brought safe and simple methods in performing facial injections to patients. Further, the market is also witnessing various mergers, acquisitions, and collaborations among the top players, which are defining the future of the Global Facial Injectables market.

Key Players: Allergan plc, Galderma S.A., Merz Pharma Gmbh & Co. KGaA, Merck & Co. Inc., Ipsen S.A., and other predominate & niche players.

Competitive Analysis: The Global Facial Injectables market is highly fragmented and has immense growth opportunities for vendors, especially in the developed regions. The presence of large, small, and local vendors in the market possess high competition. The market is dominated by Allergan, Galderma, Merz Pharma, and Ipsen. These vendors have a strong focus on acquiring smaller companies and expanding their business operations by leveraging their products portfolio across the globe. The competitive environment in the market will intensify further with an increase in product/service extensions, product innovations, and M&As. They form strategic alliances for the marketing or manufacturing of facial injectables products.

Benefits: The report provides complete details about the usage and adoption rate of facial injectables in various dermatology treatments. With that, key stakeholders can know about the major trends, drivers, investments, vertical player's initiatives, government initiatives towards the facial injectables adoption in the upcoming years along with the details of pureplay companies entering the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

Key Stakeholders:

READ MORE

Table Of Content

Scope

1 Report Outline

1.1 Report Scope

1.2 Market Definitions

1.3 Research Methodology

1.4 Report Assumptions and Declarations

2 Executive Summary

3 Market Positioning

3.1 Total Addressable Market (TAM): Medical Aesthetics Industry

3.2 Segmented Addressable Market (SAM): Facial Injectables Market

3.2.1 Market Overview

3.2.2 Major Trends

3.2.3 PEST Analysis

3.3 Related Markets

4 Market Outlook

4.1 Overview

4.2 Value Chain Analysis

4.3 Market Segmentation

4.4 Porter 5 (Five) Forces Analysis

4.5 Raw Material Analysis

4.6 Patents Analysis

5 Market Characteristics

5.1 Ecosystem

5.2 Market Segmentation

5.3 Market Dynamics

5.3.1 Drivers

5.3.2 Restraints

5.3.3 Opportunities

5.3.4 DRO-Impact Analysis

6 Facial Injectables Market by Types: Market Size and Analysis

6.1 Overview

6.2 Dermal Fillers

6.3 Botox

7 Facial Injectables Market by End Users: Market Size and Analysis

7.1 Overview

7.2 Hospitals

7.3 Dermatology Centers

7.4 Physician's Office

8 Facial Injectables Market by Regions: Market Size and Analysis

7.1 Overview

7.2 The Americas

7.3 The EMEA Region

7.4 The APAC region

8 Competitive Landscape

8.1 Overview

9 Vendor Profiles

9.1 Allergan Plc

8.2 Galderma S.A.

8.3 Merz Pharma GmbH & Co. KGaA

8.4 Ipsen S.A.

(Overview, products/services, geographic revenues, recent developments, business focus, SWOT analysis and business strategy for all vendors)

9 Companies to Watch For

9.1 Sinclair Pharma Plc

9.2 Bloomage Biotechnology Corp. Ltd.

9.3 Valeant Pharmaceuticals International Inc.

(Overview, product coverage and potential, geographic exposure, recent developments, and business strategy for all players)

Annexure

Acronyms


List Of Figure

Charts

CHART 1 FACIAL INJECTABLES SEGMENTATION BY AESTHETICS TYPES

CHART 2 MATERIALS USED IN SOFT TISSUE FILLERS

CHART 3 NUMBER OF AESTHETIC PROCEDURES PERFORMED IN THE AMERICAS

CHART 4 TOP FIVE NON-SURGICAL PROCEDURES IN 2016

CHART 5 PEST ANALYSIS OF GLOBAL FACIAL INJECTABLES MARKET

CHART 6 RESEARCH METHODOLOGY OF GLOBAL FACIAL INJECTABLES MARKET

CHART 7 WORLDWIDE FACIAL INJECTABLES MARKET REVENUE, 2016-2023 (USD MILLION)

CHART 8 PORTER 5 FORCES ON GLOBAL FACIAL INJECTABLES MARKET

CHART 9 FILLER MARKET EVOLUTION IN THE US

CHART 10 FACIAL INJECTABLES-DRO ANALYSIS

CHART 11 DRO-IMPACT ANALYSIS OF GLOBAL FACIAL INJECTABLES MARKET

CHART 12 KEY STAKEHOLDERS

CHART 13 GLOBAL FACIAL INJECTABLES MARKET BY TYPE SEGMENTATION, 2016 (%)

CHART 14 GLOBAL FACIAL INJECTABLES MARKET ATTRACTIVENESS BY PRODUCT TYPES, 2016

CHART 15 WORLDWIDE DERMAL FILLERS MARKET BY REVENUE, 2017-2023 (USD MILLION)

CHART 16 WORLDWIDE BOTOX MARKET BY REVENUE, 2017-2023 (USD MILLION)

CHART 17 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION SHARE BY PRODUCT TYPE, 2017-2023 (USD MILLION)

CHART 18 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION SHARE BY PRODUCT TYPE, 2017-2023 (%)

CHART 19 GLOBAL FACIAL INJECTABLES MARKET SHARE BY END-USER SEGMENTATION, 2016 (%)

CHART 20 BUYING CRITERIA

CHART 21 GLOBAL FACIAL INJECTABLES MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (%)

CHART 22 GLOBAL FACIAL INJECTABLES MARKET BY GEOGRAPHICAL SEGMENTATION, 2023 (%)

CHART 23 GLOBAL FACIAL INJECTABLES MARKET ATTRACTIVENESS BY REGIONS, 2016

CHART 24 FACIAL INJECTABLES MARKET REVENUE IN NORTH AMERICA, 2017-2023 (USD MILLION)

CHART 25 FACIAL INJECTABLES MARKET REVENUE IN EUROPE, 2017-2023 (USD MILLION)

CHART 26 FACIAL INJECTABLES MARKET REVENUE IN THE APAC REGION, 2017-2023 (USD MILLION)

CHART 27 FACIAL INJECTABLES MARKET REVENUE IN THE REST OF THE WORLD, 2017-2023 (USD MILLION)

CHART 28 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION BY REGIONS, 2016-2023 (USD MILLION)

CHART 29 GLOBAL FACIAL INJECTABLES MARKET SEGMENTATION BY REGIONS, 2016-2023 (%)

CHART 30 ALLERGAN PLC: OVERVIEW SNAPSHOT

CHART 31 ALLERGAN PLC: BUSINESS UNITS

CHART 32 ALLERGAN PLC: SWOT ANALYSIS

CHART 33 GALDERMA S.A.: OVERVIEW SNAPSHOT

CHART 34 GALDERMA S.A.: GEOGRAPHIC PRESENCE

CHART 35 GALDERMA S.A.: SWOT ANALYSIS

CHART 36 MERZ PHARMA GMBH & CO. KGAA: OVERVIEW SNAPSHOT

CHART 37 MERZ PHARMA GMBH & CO. KGAA: GEOGRAPHIC PRESENCE

CHART 38 MERZ PHARMA GMBH & CO. KGAA: SWOT ANALYSIS

CHART 39 IPSEN S.A.: OVERVIEW SNAPSHOT

CHART 40 IPSEN S.A.: BUSINESS UNITS

CHART 41 IPSEN S.A.: GEOGRAPHIC PRESENCE

CHART 42 IPSEN S.A.: SWOT ANALYSIS


List Of Table

Tables

TABLE 1 AVERAGE COST OF DERMAL FACIAL FILLERS

TABLE 2 GLOBAL FACIAL INJECTABLES MARKET BY TYPES, 2016-2023 (USD MILLION)

TABLE 3 DRO OF DERMAL FILLERS MARKET

TABLE 4 DRO OF BOTOX MARKET

TABLE 5 GLOBAL FACIAL INJECTABLES MARKET REVENUE FORECAST BY REGION, 2017-2023 (USD MILLION)

TABLE 6 DRO (NORTH AMERICA)

TABLE 7 DRO (EUROPE)

TABLE 8 DRO (APAC)

TABLE 9 DRO (REST OF THE WORLD)

TABLE 10 GLOBAL FACIAL INJECTABLES MARKET BY VENDOR RANKING, 2016

TABLE 11 ALLERGAN PLC: PRODUCT OFFERINGS

TABLE 12 ALLERGAN PLC: RECENT DEVELOPMENTS

TABLE 13 GALDERMA S.A.: PRODUCT OFFERINGS

TABLE 14 GALDERMA S.A.: RECENT DEVELOPMENTS

TABLE 15 MERZ PHARMA GMBH & CO. KGAA: PRODUCT OFFERINGS

TABLE 16 MERZ PHARMA GMBH & CO. KGAA: RECENT DEVELOPMENTS

TABLE 17 IPSEN S.A.: PRODUCT OFFERINGS

TABLE 18 IPSEN S.A.: RECENT DEVELOPMENTS

TABLE 19 SINCLAIR PHARMA PLC: SNAPSHOT

TABLE 20 SINCLAIR PHARMA PLC: RECENT DEVELOPMENTS

TABLE 21 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: SNAPSHOT

TABLE 22 BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED: RECENT DEVELOPMENTS

TABLE 23 VALEANT PHARMACEUTICALS INTERNATIONAL INC: SNAPSHOT

TABLE 24 VALEANT PHARMACEUTICALS INTERNATIONAL, INC.: RECENT DEVELOPMENTS

TABLE 25 OTHER VENDORS

Licence Rights

"Single User $3,500- PDF via email with only 1 user license terms or online access with login details to customer
- Multi Users $4,000- PDF via email with up to 10 user license terms
- Enterprise License $5,000- PDF via email, can be utilized across the organization and can upload in their intranet.
We do have the online access for our reports where client can utilize our knowledge store and they will have their login details to access the report online instead of PDF file."

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies


Companies

Allergan Plc, Galderma S.A., Merz Pharma GmbH & Co. KGaA, Ipsen S.A., Sinclair Pharma Plc, Bloomage Biotechnology Corp. Ltd., Valeant Pharmaceuticals International Inc.